Levocabastine (trade name Livostin) is a selective second-generation H1
receptor antagonists which was discovered at Janssen Pharmaceutica in 1979.
Physician reviewed levocabastine ophthalmic patient information - includes
levocabastine ophthalmic description, dosage and directions.
Find a comprehensive guide to possible side effects when taking Livostin (
Levocabastine) for Professionals, Patients, and Caregivers.
Learn about indications, dosage and how it is supplied for the drug Livostin (
Levocabastine is a synthetic piperidine derivative with antihistamine properties.
Levocabastine is a second generation histamine-1 receptor antagonist.
Eur J Ophthalmol. 1994 Apr-Jun;4(2):91-101. Levocabastine eye drops: a new
approach for the treatment of acute allergic conjunctivitis. Abelson MB(1) ...
Jun 13, 2005 ... Levocabastine is a selective second-generation H1-receptor antagonist used for
allergic conjunctivitis. Levocabastine was discovered at ...
LIVOSTIN™ 0.05% (levocabastine hydrochloride ophthalmic suspension) is a
selective histamine H1-receptor antagonist for topical ophthalmic use. Each mL ...
Levocabastine is a long acting, highly potent and selective histamine H1-receptor
antagonist, which has been developed for nasal and ocular administration.
Nihon Yakurigaku Zasshi. 2002 Mar;119(3):175-84. [Pharmacological and
clinical properties of levocabastine hydrochloride (eye drop and nasal spray), ...